<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02162654</url>
  </required_header>
  <id_info>
    <org_study_id>20131101-823</org_study_id>
    <nct_id>NCT02162654</nct_id>
  </id_info>
  <brief_title>Remote Ischemic Preconditioning for Intracranial Aneurysm Treatment</brief_title>
  <acronym>RIPAT</acronym>
  <official_title>The Role of Remote Ischemic Preconditioning in the Prevention of Ischemic Brain Damage During Intracranial Aneurysm Treatment (RIPAT) - A Prospective Randomized Exploratory Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University Innsbruck</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University Innsbruck</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The RIPAT study is a prospective, randomized, double-blind study organized by the
      neurovascular group of the Clinical Department of Neurosurgery of Innsbruck Medical
      University, Innsbruck, Austria. Patients aged 18+ in whom the treatment of an un-ruptured
      intracranial aneurysm is indicated are eligible for study participation. Prior to aneurysm
      treatment, with the patient already under general anesthesia, the blood supply to an arm will
      be restricted for 3x 5minutes by inflating a standard blood pressure cuff. The study
      hypothesis is that this &quot;remote ischemic preconditioning&quot; maneuver is able to prevent a
      stroke during the following treatment of the aneurysm.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective, randomized, double-blind, explorative single center clinical trial in patients
      subjected to the treatment of an un-ruptured intracranial aneurysm, either by surgical
      clipping or endovascular coiling. Goal of the study is to determine whether remote ischemic
      preconditioning (RIPC) prior to aneurysm treatment alters various biomarkers associated with
      ischemic central neuronal tissue damage. The trial takes place at Innsbruck University
      Hospital of Innsbruck Medical University, Innsbruck, Austria.

      Patients fulfilling inclusion criteria are randomly allocated either to pre-interventional
      ischemic preconditioning (Group A = intervention group) or sham preconditioning (Group B =
      control group). RIPC is performed by inflating a blood pressure cuff around one upper
      extremity three times for five minutes with five minutes interval with the patient under
      general anesthesia prior to the start of the procedure.

      Patients, all staff involved in diagnosis and treatment and all study members are blinded to
      the patients' group affiliation. The anesthesiologist and two staff members who perform
      preconditioning are not blinded.

      Primary outcome is a difference of ± 2SD in the concentration-time curve of a panel of
      biochemical parameters indicative of cerebral ischemia (S100B, NSE, GFAP, MMP9, MBP,
      microparticles) in the first five days after the intervention. Secondary outcome parameters
      are changes in the post-interventional MRI and neuropsychological and clinical outcome at six
      and 12 months.

      CONSORT and TIDieR guidelines will be followed. The trail will be registered in a public
      database. The trail protocol will be published in an open-access journal.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">November 2016</completion_date>
  <primary_completion_date type="Anticipated">November 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Area-under-Curve for biomarkers in the first 5 days after aneurysm treatment(S100B, NSE, GFAP, NSE, MMP9, Microparticles)</measure>
    <time_frame>on admission, after preconditioning but prior to intervention, at completion of intervention, at hours 3, 6, 12, 24, 48, 72, 96, 120 after completion of intervention</time_frame>
    <description>Serum biomarkers reflect brain tissue ischemic damage with various specificity and sensitivity (see Whiteley 2008, Ahmad 2012) Advantages include (1) to be available early, (2) to be continuous variables (low study n), (3) they were able to demonstrate an effect of ischemic preconditioning in other clinical studies (see Koch 2010, Veighei 2012)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number (n) of new lesions in postinterventional MRI (DWI and FLAIR)</measure>
    <time_frame>preinterventional/on day 1 or 2</time_frame>
    <description>Outcome Parameter used in other clinical studies focussing on ischemia after neurointerventional procedures (e.g. ENACT study)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical outcome ( National Institutes of Health Stroke Scale, NIHSS and modified Rankin Scale mRS)</measure>
    <time_frame>at discharge, at 6 and 12 months</time_frame>
    <description>Established outcome parameters for cerebrovascular studies. Dichotomized into favourable (NIHSS ≤1, mRS 0-1) and unfavourable</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Volume (mm3) of new lesions in postinterventional MRI (DWI and FLAIR)</measure>
    <time_frame>preinterventional, postinterventional on day 1 or 2</time_frame>
    <description>As above for number of lesions</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Neuropsychological testing VLMTA (Verbaler Lern- und Merkfähigkeitstest), the WMS-R (Zahlenspanne vorwärts und rückwärts), trail making A and B tests, the Regensburger Wortflüssigkeitstest, the TAP Wechsel verbal, the TAP and the HADS-D)</measure>
    <time_frame>preinterventional, at 6 and 12 months</time_frame>
    <description>Standard tests used in patients with cerebrovascular disorders in our departments. Not applicable to non-german-speaking patients.</description>
  </other_outcome>
  <other_outcome>
    <measure>Brain volume changes (MRI, voxel -based morphometry)</measure>
    <time_frame>Preinterventional/at the 12 months FU</time_frame>
    <description>Longterm brain volume changes that correlate with NP deficits (Horstmann 2010, Moskowitz 2011, Vuylsteke 2011) will be analyzed using voxel-based morphometry techniques</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">48</enrollment>
  <condition>Cerebral Aneurysm</condition>
  <arm_group>
    <arm_group_label>Remote ischemic preconditioning</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Inflation of a blood pressure cuff around an arm with the patient under general anesthesia prior to start aneurysm treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham preconditioning</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham inflation of a blood pressure cuff around an arm with the patient under general anesthesia prior to start aneurysm treatment</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Remote ischemic preconditioning</intervention_name>
    <description>The blood pressure cuff is inflated to 200 mmHg for 3 x 5 minutes with 5 minutes of reperfusion by complete cuff deflation each.</description>
    <arm_group_label>Remote ischemic preconditioning</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sham preconditioning</intervention_name>
    <description>The blood pressure cuff is inflated to 10 mmHg for 3 x 5 minutes with 5 minutes of complete cuff deflation each.</description>
    <arm_group_label>Sham preconditioning</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Informed written consent of patient

          -  Age &gt; 18 years

          -  Intracranial aneurysm, single or multiple, intervention as indicated by
             interdisciplinary vascular board (includes previously treated aneurysms)

          -  Normal baseline MRI

        Exclusion Criteria:

          -  Clinical or radiological signs of subarachnoid hemorrhage

          -  Planned vessel sacrifice as the primary modality for aneurysm treatment

          -  Dissecting or mycotic aneurysm

          -  Previous history of stroke or TIA within the last six months

          -  Signs or symptoms of upper and lower extremity peripheral vascular illness

          -  Drugs and lifestyle factors that interfere with biomarker Determination

          -  Inability to complete neuropsychological testing for language reasons

          -  Patients unable to have an MRI scan for any reason

          -  Previous serious cerebral disease that would preclude completion of the protocol or
             preclude MRI analysis of small strokes

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin Ortler, M.D., MSc.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Clinical Department of Neurosurgery, Innsbruck Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Martin Ortler, M.D., MSc.</last_name>
    <phone>0043-512-504</phone>
    <phone_ext>80975</phone_ext>
    <email>martin.ortler@i-med.ac.at</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Claudius Thomé, M.D.</last_name>
    <phone>0043-512-504</phone>
    <phone_ext>27452</phone_ext>
    <email>claudius.thome@i-med.ac.at</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Clinical Department of Neurosurgery, Innsbruck Medical University</name>
      <address>
        <city>Innsbruck</city>
        <zip>6020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Ortler, M.D., MSc.</last_name>
      <phone>0043-512-504</phone>
      <phone_ext>80975</phone_ext>
      <email>martin.ortler@i-med.ac.at</email>
    </contact>
    <contact_backup>
      <last_name>Selma Tülü, Cand. med.</last_name>
      <email>selma.tuelue@student.i-med.ac.at</email>
    </contact_backup>
    <investigator>
      <last_name>Martin Ortler, MD, MSc</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Claudius Thomé, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Selma Tülü, Cand.med.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Miriam Mulino, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Daniel Pinggera, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Claudia Unterhofer, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Erich Schmutzhard, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bettina Pfausler, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ronny Beer, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Raimund Helbok, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Peter Lackner, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thomas Benke, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thomas Bodner, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Margarethe Delazer, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Raffaella Matteucci-Gothe, Ph.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Uwe Siewert, Ph.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Philipp Würtinger, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrea Griesmacher, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Markus Luger, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Arnulf Benzer, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Franz Wiedermann, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Astrid Grams, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elke Gizewski, M.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>June 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 10, 2014</study_first_submitted>
  <study_first_submitted_qc>June 11, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 13, 2014</study_first_posted>
  <last_update_submitted>June 11, 2014</last_update_submitted>
  <last_update_submitted_qc>June 11, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 13, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University Innsbruck</investigator_affiliation>
    <investigator_full_name>Martin Ortler, MD MSc</investigator_full_name>
    <investigator_title>Vice Chairman, Clinical Department of Neurosurgery</investigator_title>
  </responsible_party>
  <keyword>neuroprotection</keyword>
  <keyword>ischemic preconditioning</keyword>
  <keyword>cerebral aneurysm</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Intracranial Aneurysm</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

